Welcome to the website of EFIS
News
Day of Immunology 2021 Webinar!

To celebrate the Day of Immunology 2021, EFIS and IUIS are jointly organizing a webinar on 29 April: Immunology in the time of COVID-19: achievements and opportunities. Featuring both presentations and a panel discussion, it will bring together global experts to take stock of where we are and what the future may hold. View the programme and secure your participation by registering for the webinar here, and feel free to share!
ECI 2021 goes virtual!

The ECI 2021 Organizing Committees have very closely monitored the ever-changing developments regarding the COVID-19 pandemic in the past few months. Regrettably, because the outlook presents too many uncertainties, the ECI 2021 Steering Committee, in unison with the EFIS Board, has decided to hold ECI 2021 as a virtual meeting. Continue reading here.
EFIS Vaccination Task Force Expert Report Published

Today, EFIS has published a new expert report which reviews vaccination strategies across Europe, effective scientific communication and public engagement, long-term immune monitoring programmes and equitable access to vaccines for all nations. The report has been produced by the EFIS Vaccination Task Force, a group of representatives from European immunology societies chaired by Dr Doug Brown, Chief Executive of the British Society for Immunology. The Task Force aims to address issues around COVID-19 vaccination at a European level. Download the report here.
Day of Immunology 2021

As the world continues to focus its attention, energies and resources to combat the challenges brought about by the COVID-19 pandemic, EFIS trusts that its Member Societies and their membership ranks will want to commemorate April 29, 2021 as the international Day of Immunology. Let’s use this day once again to share with the general public how critically important immunology is for global health, and to champion the expert voices from our community as a vital part of this message. Further information - including details about prizes to be awarded by EFIS and IUIS to outreach campaigns - is available here.
EFIS Welcomes the New Editor-in-Chief of Immunology Letters

Following the remote consultation held in late 2020 inviting EFIS Members to express their preference among three shortlisted Society-nominated candidates, the EFIS Board is pleased to announce the election of Luis Graça as the new Editor-in-Chief of Immunology Letters. While welcoming Dr. Graça to his appointment, the EFIS Board also wishes to express its gratitude to the Hellenic and Croatian Societies for Immunology for the impressive and certainly qualified applications of their nominees, Dr. Constantin Baxevanis and Dr. Felix Wensveen, respectively.
yEFIS Task Force Launched!

Save the Date: 6th European Congress of Immunology

Remember to save the date for the next European Congress of Immunology, September 1-4, 2021, Belgrade, Republic of Serbia.
NEWS FROM OUR OFFICIAL JOURNALS

Fa(c)t checking: How fatty acids shape metabolism and function of macrophages and dendritic cells
Increased B‐cell activity with consumption of activated monocytes in severe COVID‐19 patients
TRIM10 binds to IFN‐α/β receptor 1 to negatively regulate type I IFN signal transduction
HAMLET a human milk protein‐lipid complex induces a pro‐inflammatory phenotype of myeloid cells

Is the immunogenicity of PD-1 blocking antibodies a confounding variable in murine studies?
GILT in tumor cells improves T cell-mediated anti-tumor immune surveillance
Ageing of T-dependent B cell responses
Roles of leptin on the key effector cells of rheumatoid arthritis
The roles of STAT6 in regulating B cell fate, activation, and function
Immunotherapy in treatment of leishmaniasis
Galectin-3 in T cell-mediated immunopathology and autoimmunity
VRK2 inhibition synergizes with PD-1 blockade to improve T cell responses